Clorox (NYSE:CLX) Given New $117.00 Price Target at TD Cowen

Clorox (NYSE:CLX) had its price objective cut by TD Cowen from $120.00 to $117.00 in a research note published on Wednesday morning,MarketScreener reports. They currently have a hold rating on the stock.

Other analysts also recently issued research reports about the company. Jefferies Financial Group cut their target price on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. UBS Group dropped their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a research note on Thursday, July 17th. JPMorgan Chase & Co. boosted their price objective on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a research note on Monday, September 8th. Wells Fargo & Company dropped their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. Finally, Citigroup reissued a “neutral” rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. One research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus price target of $134.08.

Clorox Trading Down 0.5%

NYSE:CLX opened at $122.64 on Wednesday. The business has a 50 day simple moving average of $123.15 and a 200 day simple moving average of $129.96. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market capitalization of $15.00 billion, a P/E ratio of 18.81, a P/E/G ratio of 0.99 and a beta of 0.52. Clorox has a 12-month low of $116.53 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts predict that Clorox will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox’s payout ratio is currently 76.07%.

Insider Buying and Selling at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Clorox by 1.7% in the second quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after purchasing an additional 272,420 shares in the last quarter. Invesco Ltd. lifted its position in shares of Clorox by 138.3% in the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after buying an additional 1,883,465 shares during the last quarter. Norges Bank acquired a new stake in shares of Clorox in the second quarter worth about $190,429,000. Northern Trust Corp lifted its position in shares of Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after buying an additional 34,655 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after buying an additional 856,873 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.